Wallace Max N. 4
4 · Humacyte, Inc. · Filed Nov 21, 2023
Insider Transaction Report
Form 4
Humacyte, Inc.HUMA
Wallace Max N.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-11-21$1.19/sh+6,564$7,811→ 56,550 total - Exercise/Conversion
Stock Options (right to buy)
2023-11-21−6,564→ 0 totalExercise: $1.19From: 2016-11-22Exp: 2023-11-22→ Common Stock (6,564 underlying)
Signature
/s/ Max N. Wallace by Dale A. Sander as Attorney-in-Fact|2023-11-21